Abstract:OBJECTIVE:To evaluate the effects of lidocaine on changes of neuropathological outcome as well as the learning and memory abilities induced by transient global cerebral ischemia in mice of different apolipoprotein E genotypes.METHODS:Transient global ischemia was induced by bilateral common carotid arteries occlusion (BCCAO) for a period of 17 minutes. Healthy male C57BL/6J wild-type mice (C57 mice) and apolipoprotein E knockout mice (apoE mice) were randomly divided into six groups: C57 control group (n = 15, undergoing sham operation, neither BCCAO was performed nor pharmacologic intervention was given), C57 ischemia group (n = 21, BCCAO for 17 minutes was performed and normal saline was given intraperitoneally), C57 lidocaine group (n = 22, BCCAO for 17 minutes was performed and lidocaine was given intraperitoneally), apoE control group (n = 15, undergoing the same procedure as that of the C57 control group), apoE ischemia group (n = 19, undergoing the same procedure as that of the C57 ischemia group), apoE lidocaine group (n = 16, undergoing the same procedure as that of the C57 lidocaine group). The mice were allowed to recover for 7 days. Twenty-eight mice were randomly selected from these 6 groups for neuropathological studies on the 7 th postoperative day. The percentage of ischemic neurons in the CA1 region of hippocampus was calculated. Morris water maze tasks were performed for the rest mice from the 8 th postoperative day. Mice were tested four times daily for 5 consecutive days. The latency period was recorded and the percentage of effective search strategies were calculated.RESULTS:(1) The percentage of ischemic neurons in the CA1 region of hippocampus was 0.3% +/- 0.1% in the C57 control group, 19.3% +/- 4.5% in the C57 ischemia group, 36.9% +/- 2.5% in the C57 lidocaine group, 0.6% +/- 0.3% in the apoE control group, 65.5% +/- 2.2% in the apoE ischemia group, and 39.4% +/- 6.5% in the apoE lidocaine group, significantly higher in the ischemia and lidocaine groups than in the corresponding control groups (all P < 0.01), significantly higher in the C57 lidocaine and apoE ischemia groups than in the C57 ischemia group (both P < 0.01), however, significantly lower in the apoE lidocaine group than in the apoE ischemia group (both P < 0.01). (2) The latency period decreased significantly along with the test days in all groups except in the apoE ischemia group (P < 0.05 or 0.01), significantly longer in the ischemia and lidocaine groups than in the corresponding control groups (P < 0.05 or 0.01), significantly longer in the C57 lidocaine group than in the C57 ischemia group on the 3 rd day of test [73.1 (22.1-120.1) s vs. 40.2 (28.4-91.1) s], and in the apoE ischemia group than in the C57 ischemia group on the 3 rd and 4 th days of test [88.2 (41.0-120.1) s vs. 40.2 (28.4-91.1) s, and 78.2 (32.9-120.1) s vs. 46.3 (11.6-81.9) s] (P < 0.05 or 0.01), and, however, significantly shorter in the apoE lidocaine group than in the C57 lidocaine group on the 3rd day of test [39.0 (15.5-103.5) s vs. 73.1 (22.1-120.1) s], and in the apoE lidocaine group than in the apoE ischemia group from the 3 rd to the 5 th days of test [39.0 (15.5-103.5) s vs. 88.2 (41.0-120.1) s, 24.9 (11.8-68.0) s vs. 78.2 (32.9-120.1) s, and 29.1 (6.6-57.2) s vs. 66.3 (14.2-97.0) s respectively] (P < 0.05 or 0.01). (3) The percentage of effective search strategy increased significantly along with the test day in all groups except in the C57 lidocaine and apoE ischemia groups (P < 0.05 or 0.01), significantly lower in the ischemia and lidocaine groups than in the corresponding control groups (P < 0.05 or 0.01), significantly lower in the C57 lidocaine group than in the C57 ischemia group on the 4 th and 5 th days of test [25 (0-50)% vs. 50 (25-75)% and 37.5 (0-75)% vs. 50 (50-100)%], and in the apoE ischemia group than in the C57 ischemia group from the 3 rd to the 5th days of test [25 (0-25)% vs. 50 (25-75)%, 25 (0-25)% vs. 50 (25-75)%, and 25 (0-50)% vs. 50 (50-100)% respectively] (P < 0.05 or 0.01), and, however, significantly higher in the apoE lidocaine group than in the C57 lidocaine group [50 (0-75)% vs. 25 (0-50)% and 50 (25-100)% vs. 37.5 (0-75)%], and in the apoE lidocaine group than in apoE ischemia group [50 (0-75)% vs. 25 (0-25)% and 50 (25-100)% vs. 25 (0-50)%] on the 4 th and 5 th days of test (all P < 0.05).CONCLUSION:Transient global cerebral ischemia causes significant brain damage, which is more severe in the apoE mice than in the C57 mice. Lidocaine significantly worsens the ischemic brain damage in the C57 mice, and, however, significantly alleviates the ischemic cerebral result in the apoE mice.

Influences of ALEC on lipid Peroxidation and energy metabolism after mouse brain injury

Influences of ALEC on reduced glutathione after mouse brain injury:a randomized and orthogonal trial

Protective effects of ALEC on ischemic injury of rat brain

Influences of ALEC on ecog and apoptosis of hippocampus neural cells in rat brain ischemia

[Study of the Effects of Auricularia Auricular Polysaccharide on Local Ischemia/reperfusion Injury in Rat].

Effects of ambroxol on nuclear factor-kappa B signaling transduction in lipopolysaccaride-induced acute lung injury in rats

The effects of lycopene on reactive oxygen species and anoxic damage in ischemia reperfusion injury in rats

Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injury

Protective effect of alpha-lipoic acid on bisphenol A-induced learning and memory impairment in developing mice: nNOS and keap1/Nrf2 pathway

Neuroprotective effects of allicin on ischemia-reperfusion brain injury

The Protective Effect of Alpha-Lipoic Acid Against Brain Ischemia and Reperfusion Injury Via Mtor Signaling Pathway in Rats

Ethanolic extract of Arctium lappa leaves alleviates cerebral ischemia reperfusion-induced inflammatory injury via HDAC9-mediated NF-κB pathway

A possible role of lipid peroxidation in cellular damages caused by cerebral ischemia and the protective effect of alpha-tocopherol administration.

Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation

Inhibition of Anaplastic Lymphoma Kinase Protects From Ischemic Stroke

[Effects of Lidocaine on Brain Damage Induced by Transient Global Cerebral Ischemia in Mice of Different Apolipoprotein E Genotypes].

CHANGES OF THE SERUM LEVELS OF THE MDA AND GSH WITH THE TREATMENT OF ALFA TOCOPHEROL IN THE EXPERIMENTAL BRAIN INJURY

Cepharanthine Attenuates Early Brain Injury after Subarachnoid Hemorrhage in Mice via Inhibiting 15-Lipoxygenase-1-Mediated Microglia and Endothelial Cell Ferroptosis

Alpha-lipoic Acid Pre- and Post-Treatments Provide Protection Against in Vitro Ischemia-Reperfusion Injury in Cerebral Endothelial Cells Via Akt/mTOR Signaling

Alpha-Linolenic Acid Impedes Cadmium-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration in Mouse Brain

Alpha Lipoic Acid Inhibits Neural Apoptosis Via a Mitochondrial Pathway in Rats Following Traumatic Brain Injury